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Abstract
Purpose Genital ureaplasmas are considered opportunis-
tic pathogens of human genitourinary tract involved in
adverse pregnancy sequelae and infertility. While associ-
ation of Ureaplasma urealyticum with urogenital tract
infections is well established, the role of Ureaplasma
parvum in these infections is still insufficient. In the study,
we compared how often cervicovaginal colonization with
U. parvum is associated with the presence of these
microorganisms in the upper genitourinary tract of fertile
and infertile women.
Methods We used PCR assay to determine the prevalence
of U. parvum and U. urealyticum in pairs of specimens,
i.e., vaginal swabs and Douglas’ pouch fluid samples from
consecutive 40 women with no symptoms of genital tract
infection.
Results In total, 19 (47.5 %) of the 40 samples were
positive for ureaplasmas. U. parvum was simultaneously
detected in pairs of samples in five (55.5 %) of the nine
(47.4 %) women positive in PCR assay. As many as 5
(18.5 %) of the 27 infertile women and 1 (7.7 %) of the 13
fertile women showed infection of the upper genital tract
with U. parvum.
Conclusion The results of the study demonstrated that
colonization of the lower genital tract with U. parvum
can produce asymptomatic infection of the upper repro-
ductive system in women. These findings also imply that
U. parvum may be present in the upper genital tract at the
time of conception and might be involved in adverse
pregnancy outcomes.
Keywords Ureaplasma parvum  Ureaplasma
urealyticum  Upper urogenital tract  Asymptomatic
infection
Introduction
Mycoplasmataceae family comprises pleomorphic, cell
wall deficient bacteria of Mycoplasma and Ureaplasma
genera, referred to collectively as mycoplasmas [1, 2].
Genital ureaplasmas, i.e., U. urealyticum (biovar 2 com-
prising serotypes 2, 4, 5, 7 and from 7 to 13) and U. parvum
(biovar 1, serotypes 1, 3, 6 and 14) are considered natural
inhabitants of the lower urogenital tract of humans as they
are often isolated from healthy individuals [3, 4]. On the
other hand, ureaplasmas are involved in a variety of
infections in humans. There are several reports confirming
the association of U. urealyticum with nongonococcal
urethritis, infertility, postpartum endometriosis, chorioam-
nionitis, spontaneous abortion, stillbirth, premature birth
and perinatal morbidity and mortality [1, 2, 5]. While
association of U. urealyticum with urogenital tract infec-
tions is well established, the role of U. parvum in these
infections is still insufficient and underestimated, mostly
because of lack of ureaplasma species differentiation.
Nevertheless, the isolation of U. parvum from subjects with
genitourinary tract infections as well as findings of studies
on laboratory animals seems to confirm the pathogenicity
of the species [6]. De Francesco et al. [7] have found
U. parvum serovar 3/14 in 86 % of women with symp-
tomatic genital tract infections. Similarly, Kong et al. [8]
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have identified U. parvum in vaginal swabs of 87 %
pregnant women. U. parvum has also been linked with
adverse pregnancy outcomes such as late abortion and
early preterm birth [9]. Kacerovsky et al. [10] identified U.
parvum in 57 % of healthy nonpregnant women and the
organism was far more prevalent than any of the other
genital mycoplasmas, Chlamydia spp. or viruses.
The pathomechanism of infections caused by genital
ureaplasmas is not fully elucidated;however, several viru-
lence factors, i.e., IgA protease, phospholipases A and C as
well as hemolytic activity and attachment to the host cell
have been described in Ureaplasma species. Moreover, it
has been showed that long-lasting colonization of mucosal
membranes of the lower urogenital tract and immune
response to ureaplasmal antigens stimulated inflammation
demonstrated by elevated levels of proinflammatory cyto-
kines e.g., interleukin-6 (IL-6) and IL-8 [5, 11].
Most studies linking ureaplasmas with genital tract
infections, adverse pregnancy outcomes or infertility are
limited to sampling the lower genital tract, thus yielding
inconclusive results and complicating an understanding the
potential role of U. parvum in the reproductive tract
infections. The study was undertaken to elucidate whether
the colonization of the lower urogenital tract with U. par-
vum can produce ascending asymptomatic infection of the
upper genital tract in nonpregnant fertile and infertile
women. In the study, PCR assay was used to determine the
prevalence of U. parvum and U. urealyticum in pairs of
specimens, i.e., vaginal swabs and Douglas’ pouch fluid
samples obtained from consecutive 40 women with no
symptoms of infection of the urogenital tract that were
subjected to diagnostic laparoscopy.
Materials and methods
Patients’ specimens
The study was carried out on pairs of specimens
obtained from a consecutive 40 women (aged
22–38 years) living in Lower Silesia region, Poland, that
were admitted to the Gynecology Clinic at the Depart-
ment of Gynecology and Obstetrics of Wrocław Uni-
versity of Medicine for diagnostics laparoscopy. A
detailed gynecological examination and a general physi-
cal examination were performed on all women, which
made it possible to exclude women with symptoms of
reproductive system infection. The primary infertility
was diagnosed in 27 women among whose 14 (51.8 %)
had unexplained or idiopathic infertility, six (22.2 %)
suffered from tubal obstruction diagnosed by laparos-
copy, three (11.1 %) presented ovulation disorders and
endometriosis, and four (14.8 %) had no overt
abnormalities but whose partners showed sperm irregu-
larities that were suspected of preventing conception.
Thirteen women with proven fertility (history of giving
birth to at least one child) had diagnosed laparoscopi-
cally benign ovarian tumors and uterine myomas. Cer-
vical swabs were collected using a sterile flocked swabs
(Copan, Italy) and transferred into one-tube DNA puri-
fication system (OTP—Reagent, Bioron, Germany) con-
tainer. A 1 ml of fluid aspirated from the pouch of
Douglas was transferred into sterile tube and immedi-
ately frozen at -20 C. Samples were transported to the
laboratory within 1–3 h after collection. In both speci-
mens obtained from every woman the presence of
common urogenital pathogens e.g., Chlamydia tracho-
matis, Neisseria gonorrhoeae, group B streptococci, was
excluded by specific microbiological examination.
PCR assay
Genomic DNA from cervical swabs was extracted using
commercial kit according to OTP—Reagent protocol. The
resultant DNA was frozen at -20 C for further analysis.
DNA isolation from frozen Douglas’ pouch fluid was
carried out using QIAamp DNA kit (Qiagen, Hilden,
Germany) in accordance with supplier’s protocol. Gene-
Proof Mycoplasma species PCR IVD CE kit (GeneProof,
Czech Republic) was used to detect all clinically signifi-
cant human mycoplasmas and ureaplasmas. In brief, PCR
was performed in 40 ll volumes containing 4 ll of iso-
lated DNA sample and 36 ll of an optimized ready-to-use
solution of MasterMix at the following conditions: UNG
was activated for 2 min at 37 C followed by 15 min at
96 C of DNA denaturation. PCR amplification consisted
of 45 cycles at 95 C for 1 min; 69 C for 15 s; and
68 C for 30 s. Final extension step was carried at 72 C
for 5 min. Samples positive for Mycoplasma spp. were
further investigated for ureaplasmas using GenePack
DNA PCR tests: U. parvum biovar 1 (Upa) and U. ure-
alyticum biovar 2 (Uur) (Bioron, Germany). All reagents
required for this PCR (Taq DNA polymerase, dNTPs,
specific primers, salts, and stabilizers) were lyophilized in
PCR tubes by manufacturer, for final reaction volume of
20 ll. 3 ll of DNA sample, 10 ll specific buffer provided
in the kit, and 7 ll of PCR grade sterile water, were
added. Amplification was performed under the following
conditions: 95 C for 2 min, followed by 45 cycles of
95 C for 1 min, 58 C for 40 s and 74 C for 1 min. A
final elongation step was performed at 74 C for 2 min.
All PCR amplifications were performed in a DNA—
Engine PT200 thermal cycler (MJ Research Waltham,
MA, USA). PCR products were visualized after electro-
phoresis on a 2 % agarose gel in Tris-acetate–EDTA
buffer by staining with ethidium bromide.
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Results
Altogether, 21 (52.5 %) of the 40 samples were positive
with Mycoplasma spp. and 19 (47.5 %) samples were
negative. Among these 21 positive for genital Mycoplasma
specimens, as many as 19 (90.5 %) showed positive PCR
reaction for ureaplasmas: nine (42.8 %) for U. parvum and
ten (47.6 %) for U. urealyticum. There was no samples
positive for these both U. parvum and U. urealyticum
species. The remaining two (9.5 %) samples represented
other than ureaplasmas genital Mycoplasma species.
Colonization of the lower genitourinary tract with
U. parvum was shown eight, (42.1 %) women among
whom six (66.7 %) had also positive PCR result in
Douglas’ pouch fluid samples. U. urealyticum was
simultaneously detected in pairs of samples in seven
(70 %) out of the ten (52.6 %) women infected with the
microorganism (Tables 1, 2, 3). These results indicated
that in more than 60 % of women carrying of U. parvum
or U. urealyticum in the lower genitourinary tract
ascending infection of the upper, sterile parts of the
genitourinary tract occurred.
Table 1 The occurrence of positive and negative PCR reactions







Infertile women (n = 27)
Idiopathic infertility (n = 14)
1 ? – ?
2 – – –
3 – – –
4 ? ? –
5 ? ? –
6 ? – –
7 ? – ?
8 ? ? –
9 – – –
10 ? ? –
11 ? – ?
12 – – –
13 ? – –
14 – – –
Tubal obstruction (n = 6)
1 ? – ?
2 ? – –
3 – – –
4 – – –
5 – – –
6 ? – ?
Ovulation disorders,
endometriosis (n = 3)
1 ? ? –
2 ? ? –
3 – – –
Sperm irregularity (n = 4)
1 – – –
2 – – –
3 ? ? –
4 ? – ?
Fertile women (n = 13)
1 ? ? –
2 ? – ?
3 – – –
4 – – –
5 – – –
6 – – –
7 – – –
8 – – –
9 ? – ?
10 – – –
11 ? ? –
12 ? – ?
13 – – –
Table 2 The prevalence of U. parvum and U. urealyticum in 19
ureaplasma-positive paired samples
No. of positive samples U. parvum U. urealyticum Total
Total 9 (47.4 %) 10 (52.6 %) 19 (100 %)
Cs 8 (42.1 %) 10 (52.6 %) 18 (94.7 %)
Df 6 (31.6 %) 7 (36.8 %) 13 (68.4 %)
Cs ? Df 5 (26.3 %) 7 (36.8 %) 12 (63.1 %)
Cs cervical swab, Df Douglas pouch fluid
Table 3 The prevalence of U. parvum and U. urealyticum in paired




n = 27 (67.5 %)
Fertile women





Total 7 (25.9 %) 2 (15.4 %) 9 (22.5 %)
Cs 6 (22.2 %) 2 (15.4 %) 8 (20 %)
Df 5 (18.5 %) 1 (7.7 %) 6 (15 %)
Cs ? Df 4 (14.8 %) 1 (7.7 %) 5 (12.5 %)
U. urealyticum
Total 7 (25.9 %) 3 (23.1 %) 10 (25 %)
Cs 7 (25.9 %) 3 (23.1 %) 10 (25 %)
Df 5 (18.5 %) 2 (15.4 %) 7 (17.5 %)
Cs ? Df 5 (18.5 %) 2 (15.4 %) 7 (17.5 %)
Cs cervical swab, Df Douglas pouch fluid
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In the study, we also analyzed if there is any relationship
between the infection of the upper genitourinary tract
caused by ureaplasmas and infertility (Table 3). Infection
of the upper genitourinary tract was confirmed by the
detection of U. parvum in five (18.5 %) of the 27 infertile
women and in one (7.7 %) of the 13 fertile women. Similar
result was related to U. urealyticum. Although, there was
no statistical differences between these two groups of
women, infection of the upper genitourinary tract was more
common among infertile women (p [ 0.05).
Generally, the results of the study showed that U. par-
vum can produce asymptomatic infections of the upper
genital tract in women carrying these organisms in the
lower urogenital tract as frequently as U. urealyticum.
Discussion
Albeit the implication of ureaplasmas in lower urogenital
tract infections and their adverse effect on pregnancy seem to
be well established, their role in the upper genitourinary tract
infection is not so obvious. Difficulty in the routine detection
of ureaplasmas caused by their fastidious growth require-
ments, but also lack of susceptible and rapid assays as well as
need to obtain specimens from the upper genitourinary tract
using invasive procedures, make the relationship of ureapl-
asmas with these infections underestimated [1, 2]. There are
many reports linking ureaplasmas with infertility. Indeed,
genital ureaplasmas are isolated more commonly from
infertile subjects than than from healthy controls [5, 12, 13].
The association of genital ureaplasmas with a variety of
pathological conditions in women is based on the detection
of these potential pathogens in the specimens from the
lower genitourinary tract e.g., vaginal or endocervical
swabs. However, there is little if any evidence document-
ing the detection of ureaplasmas in the sterile samples from
the upper genitourinary tract of asymptomatic women.
Colonization of the vagina or cervix with ureaplasmas can
lead to the ascending infection of the upper genital tract
with subsequent inflammation of these structures. Long-
lasting inflammation within upper genital tract can cause
scarring of the inflamed tissue and can contribute to the
development of reproductive system disorders such as
infertility [5].
While the association of U. urealyticum with the uro-
genital tract infections is well established, the role of
U. parvum in these infections is still insufficient. Moreover,
the presence of U. parvum in the lower urogenital tract of
many healthy nonpregnant women complicates an under-
standing of the potential role of these microorganisms in
adverse outcomes of pregnancy and reproductive system
disorders. In the study we have compared the prevalence of
U. parvum and U. urealyticum in pairs of specimens, i.e.,
vaginal swabs and Douglas’ pouch fluid samples obtained
during the laparoscopy from consecutive 40 women with
no symptoms of the urogenital tract infection. Both these
species, U. parvum and U. urealyticum were detected in
Douglas’ pouch fluid samples in about 60 % of women
carrying ureaplasmas in the lower urogenital tract, con-
firming that cervicovaginal colonization can lead to the
direct ascent of ureaplasmas to the sterile upper repro-
ductive tract. To our knowledge this is the first report on
the detection of U. parvum in Douglas’ pouch fluid samples
from women without any signs of the upper genital tract
infection. The findings of the study indicated that U. par-
vum, similarly to U. urealyticum, can produce asymptom-
atic infection of the upper genital tract in women. The
presence of these organisms in the sterile part of the genital
tract may induce long-lasting subacute inflammation that
may be the cause of the upper genital tract disorders e.g.,
infertility. Zhu et al. [14] in the study of pathogenicity of
U. parvum serotypes 1, 3, and 6, and U. urealyticum ser-
otypes 4 and 8 for BALB/c female mice showed that all
these serotypes caused morphological changes of the
external genitalia associated with infiltration by inflam-
matory cells and increased tumor necrosis factor-a (TNF-
a) expression. Similarly, Shimizu et al. [15] indicated that
U. parvum lipoproteins activated nuclear factor NF-jB
thus inducing the synthesis of tumor necrosis factor alpha
(TNF-a) in mouse peritoneal macrophages. Allam et al. [6]
in their study on bladder tissue from animals actively
colonized by U. parvum demonstrated significant altera-
tions in actin binding proteins that may influence cell sig-
naling cascades regulating cell motility, differentiation,
apoptosis, and inflammation. Moreover, they have shown
in a rats experimentally infected with U. parvum three
clinical outcomes of infection, i.e., clearance of infection
within 2 weeks in one-third of animals, then asymptomatic
infection and acute, complicated infection of bladder
associated with the presence of ureaplasmas within bladder
submucosa. Their study pointed out that the effect of
infections caused by U. parvum depends on the host-
associated factors. Most localized to the lower urogenital
tract infections caused by ureaplasmas characterize
asymptomatic or subclinical course due to limited immune
response. On the other hand, there are several reports on
the disseminated, acute ureaplasmal infections that occur
mostly among neonates and immunosuppressed individu-
als, indicating the significance of the host immune response
in the clinical outcome of these infections [16–19]. All
these reports confirmed pathogenicity of U. parvum for the
host cells and indicated that the occurrence of these
organisms in the genitourinary tract is associated with
inflammatory response. Demonstrated in the study, the
presence of U. parvum and U. urealyticum in the Douglas’
pouch, even asymptomatic, implies that immune response
1132 Arch Gynecol Obstet (2014) 289:1129–1134
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against these organisms seem to be inevitable and may
produce chronic inflammation with subsequent develop-
ment of abnormalities within upper genitourinary tract of
women.
In addition, in the study we compared the prevalence of
both, U. parvum and U. urealyticum in the specimens
obtained from fertile and infertile women. The results
showed that the upper genitourinary tract infection with
Ureaplasma spp. was more common among infertile than
fertile women what is in concordance with Dhawan et al. [13]
who have shown the predominance of U. parvum serovar
3/14 in patients with genital infections and infertility.
The results of the study also raised the problem of
treating ureaplasma-positive individuals. Taking into con-
sideration pathogenic potential of these bacteria, and the
fact that most infections caused by Ureaplasma spp. are
mild or unnoticeable, and that the colonization of the lower
genitourinary tract with ureaplasmas is common, general
rules should be established.
Since many investigators have shown using quantitative
techniques that the degree of colonization with Urea-
plasma spp. is correlated with clinical presentation and
adverse outcomes [4, 20], the decision whether the pre-
sence of ureaplasmas in the genitourinary tract should be
treated depends on the specimen and the concentration of
ureaplasmas in the specimen. In case of specimens
obtained from the lower genitourinary tract colonized by
normal flora, culture or/and commercially available diag-
nostic kits should be used instead of sensitive molecular
methods. Many available screening tests allow to detect
ureaplasmas and, what is more important, to establish their
load. The concentration of ureaplasmas in the specimen
from the lower genitourinary tract amounting C104
organisms per ml is commonly accepted as the load indi-
cating an infection that should be treated with antimicro-
bials. Lower concentrations (\104 organisms per ml) of
ureaplasmas in all specimens from the lower genitourinary
tract are considered colonization that does not need
treatment. In case of specimens obtained from the upper
genitourinary tract, the load of ureaplasmas is not as
important as in case of specimens from the lower genito-
urinary tract as the occurrence of ureaplasmas in the sterile
body sites is always considered an infection that should
be treated. Thus, the detection of ureaplasmas in all spec-
imens obtained from the upper genitourinary tract should
rely on sensitive molecular methods that allow detecting
even low concentrations of ureaplasmas within specimens
as well as enabling their identification to the species
level. Moreover, treatment should include infection in both,
men and women and their sexual contacts.
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